Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats

Detalhes bibliográficos
Autor(a) principal: Lucas Miranda Kangussu
Data de Publicação: 2021
Outros Autores: Marcella Nunes de Melo Braga, Bruna Soares de Souza Lima Rodrigues, Robson Augusto Souza dos Santos, Hélida Monteiro de Andrade, Maria José Campagnole dos Santos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFMG
Texto Completo: https://doi.org/10.3389/fnins.2021.624249
http://hdl.handle.net/1843/56302
https://orcid.org/0000-0003-3678-118X
https://orcid.org/0000-0002-6174-8157
https://orcid.org/0000-0003-2823-4530
https://orcid.org/0000-0001-9483-4206
Resumo: Previous data showed hypertensive rats subjected to chronic intracerebroventricular (ICV) infusion of angiotensin-(1-7) presented attenuation of arterial hypertension, improvement of baroreflex sensitivity, restoration of cardiac autonomic balance and a shift of cardiac renin-angiotensin system (RAS) balance toward Ang-(1-7)/Mas receptor. In the present study, we investigated putative central mechanisms related to the antihypertensive effect induced by ICV Ang-(1-7), including inflammatory mediators and the expression/activity of the RAS components in hypertensive rats. Furthermore, we performed a proteomic analysis to evaluate differentially regulated proteins in the hypothalamus of these animals. For this, Sprague Dawley (SD) and transgenic (mRen2)27 hypertensive rats (TG) were subjected to 14 days of ICV infusion with Ang-(1-7) (200 ng/h) or 0.9% sterile saline (0.5 µl/h) through osmotic mini-pumps. We observed that Ang-(1-7) treatment modulated inflammatory cytokines by decreasing TNF-α levels while increasing the anti-inflammatory IL-10. Moreover, we showed a reduction in ACE activity and gene expression of AT1 receptor and iNOS. Finally, our proteomic evaluation suggested an anti-inflammatory mechanism of Ang-(1-7) toward the ROS modulators Uchl1 and Prdx1.
id UFMG_b760616c421f0fb2f2342daa568cdb58
oai_identifier_str oai:repositorio.ufmg.br:1843/56302
network_acronym_str UFMG
network_name_str Repositório Institucional da UFMG
repository_id_str
spelling 2023-07-14T20:36:54Z2023-07-14T20:36:54Z2021-04-2315https://doi.org/10.3389/fnins.2021.6242491662-453Xhttp://hdl.handle.net/1843/56302https://orcid.org/0000-0003-3678-118Xhttps://orcid.org/0000-0002-6174-8157https://orcid.org/0000-0003-2823-4530https://orcid.org/0000-0001-9483-4206Previous data showed hypertensive rats subjected to chronic intracerebroventricular (ICV) infusion of angiotensin-(1-7) presented attenuation of arterial hypertension, improvement of baroreflex sensitivity, restoration of cardiac autonomic balance and a shift of cardiac renin-angiotensin system (RAS) balance toward Ang-(1-7)/Mas receptor. In the present study, we investigated putative central mechanisms related to the antihypertensive effect induced by ICV Ang-(1-7), including inflammatory mediators and the expression/activity of the RAS components in hypertensive rats. Furthermore, we performed a proteomic analysis to evaluate differentially regulated proteins in the hypothalamus of these animals. For this, Sprague Dawley (SD) and transgenic (mRen2)27 hypertensive rats (TG) were subjected to 14 days of ICV infusion with Ang-(1-7) (200 ng/h) or 0.9% sterile saline (0.5 µl/h) through osmotic mini-pumps. We observed that Ang-(1-7) treatment modulated inflammatory cytokines by decreasing TNF-α levels while increasing the anti-inflammatory IL-10. Moreover, we showed a reduction in ACE activity and gene expression of AT1 receptor and iNOS. Finally, our proteomic evaluation suggested an anti-inflammatory mechanism of Ang-(1-7) toward the ROS modulators Uchl1 and Prdx1.Dados anteriores mostraram que ratos hipertensos submetidos à infusão crônica intracerebroventricular (ICV) de angiotensina-(1-7) apresentaram atenuação da hipertensão arterial, melhora da sensibilidade do barorreflexo, restauração do equilíbrio autonômico cardíaco e alteração do equilíbrio do sistema renina-angiotensina (SRA) cardíaco para o receptor Ang-(1-7)/Mas. No presente estudo, investigamos os supostos mecanismos centrais relacionados ao efeito anti-hipertensivo induzido pelo ICV Ang-(1-7), incluindo mediadores inflamatórios e a expressão/atividade dos componentes do SRA em ratos hipertensos. Além disso, realizamos uma análise proteômica para avaliar proteínas diferencialmente reguladas no hipotálamo desses animais. Para isso, ratos Sprague Dawley (SD) e transgênicos (mRen2)27 hipertensos (TG) foram submetidos a 14 dias de infusão ICV com Ang-(1-7) (200 ng/h) ou soro fisiológico 0,9% estéril (0,5 µl/ h) através de minibombas osmóticas. Observamos que o tratamento com Ang-(1-7) modulou as citocinas inflamatórias diminuindo os níveis de TNF-α e aumentando o anti-inflamatório IL-10. Além disso, mostramos uma redução na atividade da ECA e na expressão gênica do receptor AT1 e iNOS. Finalmente, nossa avaliação proteômica sugeriu um mecanismo anti-inflamatório de Ang-(1-7) para os moduladores de ROS Uchl1 e Prdx1.CNPq - Conselho Nacional de Desenvolvimento Científico e TecnológicoFAPEMIG - Fundação de Amparo à Pesquisa do Estado de Minas GeraisCAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorengUniversidade Federal de Minas GeraisUFMGBrasilICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICAICB - DEPARTAMENTO DE MORFOLOGIAICB - DEPARTAMENTO DE PARASITOLOGIAFrontiers in NeuroscienceAngiotensinasHipotálamoRatos transgênicosHipertensãoCitocinasÓxido nítrico sintase tipo IIBarorreflexoProteômicaAngiotensin-(1-7)HypothalamusHypertensive transgenic (mRen2)27 ratsCytokinesiNOSROS modulatorsAngiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 ratsMecanismos centrais de angiotensina-(1-7) após infusão ICV em ratos hipertensos transgênicos (mRen2)27info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://www.frontiersin.org/articles/10.3389/fnins.2021.624249/fullLucas Miranda KangussuMarcella Nunes de Melo BragaBruna Soares de Souza Lima RodriguesRobson Augusto Souza dos SantosHélida Monteiro de AndradeMaria José Campagnole dos Santosapplication/pdfinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGLICENSELicense.txtLicense.txttext/plain; charset=utf-82042https://repositorio.ufmg.br/bitstream/1843/56302/1/License.txtfa505098d172de0bc8864fc1287ffe22MD51ORIGINALAngiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats.pdfAngiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats.pdfapplication/pdf73178979https://repositorio.ufmg.br/bitstream/1843/56302/2/Angiotensin-%281-7%29%20central%20mechanisms%20after%20ICV%20infusion%20in%20hypertensive%20transgenic%20%28mRen2%2927%20rats.pdf74f9266c9a8ba2aaa978267f85ab148eMD521843/563022023-07-14 17:36:54.247oai:repositorio.ufmg.br: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Repositório de PublicaçõesPUBhttps://repositorio.ufmg.br/oaiopendoar:2023-07-14T20:36:54Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false
dc.title.pt_BR.fl_str_mv Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
dc.title.alternative.pt_BR.fl_str_mv Mecanismos centrais de angiotensina-(1-7) após infusão ICV em ratos hipertensos transgênicos (mRen2)27
title Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
spellingShingle Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
Lucas Miranda Kangussu
Angiotensin-(1-7)
Hypothalamus
Hypertensive transgenic (mRen2)27 rats
Cytokines
iNOS
ROS modulators
Angiotensinas
Hipotálamo
Ratos transgênicos
Hipertensão
Citocinas
Óxido nítrico sintase tipo II
Barorreflexo
Proteômica
title_short Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
title_full Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
title_fullStr Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
title_full_unstemmed Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
title_sort Angiotensin-(1-7) central mechanisms after ICV infusion in hypertensive transgenic (mRen2)27 rats
author Lucas Miranda Kangussu
author_facet Lucas Miranda Kangussu
Marcella Nunes de Melo Braga
Bruna Soares de Souza Lima Rodrigues
Robson Augusto Souza dos Santos
Hélida Monteiro de Andrade
Maria José Campagnole dos Santos
author_role author
author2 Marcella Nunes de Melo Braga
Bruna Soares de Souza Lima Rodrigues
Robson Augusto Souza dos Santos
Hélida Monteiro de Andrade
Maria José Campagnole dos Santos
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Lucas Miranda Kangussu
Marcella Nunes de Melo Braga
Bruna Soares de Souza Lima Rodrigues
Robson Augusto Souza dos Santos
Hélida Monteiro de Andrade
Maria José Campagnole dos Santos
dc.subject.por.fl_str_mv Angiotensin-(1-7)
Hypothalamus
Hypertensive transgenic (mRen2)27 rats
Cytokines
iNOS
ROS modulators
topic Angiotensin-(1-7)
Hypothalamus
Hypertensive transgenic (mRen2)27 rats
Cytokines
iNOS
ROS modulators
Angiotensinas
Hipotálamo
Ratos transgênicos
Hipertensão
Citocinas
Óxido nítrico sintase tipo II
Barorreflexo
Proteômica
dc.subject.other.pt_BR.fl_str_mv Angiotensinas
Hipotálamo
Ratos transgênicos
Hipertensão
Citocinas
Óxido nítrico sintase tipo II
Barorreflexo
Proteômica
description Previous data showed hypertensive rats subjected to chronic intracerebroventricular (ICV) infusion of angiotensin-(1-7) presented attenuation of arterial hypertension, improvement of baroreflex sensitivity, restoration of cardiac autonomic balance and a shift of cardiac renin-angiotensin system (RAS) balance toward Ang-(1-7)/Mas receptor. In the present study, we investigated putative central mechanisms related to the antihypertensive effect induced by ICV Ang-(1-7), including inflammatory mediators and the expression/activity of the RAS components in hypertensive rats. Furthermore, we performed a proteomic analysis to evaluate differentially regulated proteins in the hypothalamus of these animals. For this, Sprague Dawley (SD) and transgenic (mRen2)27 hypertensive rats (TG) were subjected to 14 days of ICV infusion with Ang-(1-7) (200 ng/h) or 0.9% sterile saline (0.5 µl/h) through osmotic mini-pumps. We observed that Ang-(1-7) treatment modulated inflammatory cytokines by decreasing TNF-α levels while increasing the anti-inflammatory IL-10. Moreover, we showed a reduction in ACE activity and gene expression of AT1 receptor and iNOS. Finally, our proteomic evaluation suggested an anti-inflammatory mechanism of Ang-(1-7) toward the ROS modulators Uchl1 and Prdx1.
publishDate 2021
dc.date.issued.fl_str_mv 2021-04-23
dc.date.accessioned.fl_str_mv 2023-07-14T20:36:54Z
dc.date.available.fl_str_mv 2023-07-14T20:36:54Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1843/56302
dc.identifier.doi.pt_BR.fl_str_mv https://doi.org/10.3389/fnins.2021.624249
dc.identifier.issn.pt_BR.fl_str_mv 1662-453X
dc.identifier.orcid.pt_BR.fl_str_mv https://orcid.org/0000-0003-3678-118X
https://orcid.org/0000-0002-6174-8157
https://orcid.org/0000-0003-2823-4530
https://orcid.org/0000-0001-9483-4206
url https://doi.org/10.3389/fnins.2021.624249
http://hdl.handle.net/1843/56302
https://orcid.org/0000-0003-3678-118X
https://orcid.org/0000-0002-6174-8157
https://orcid.org/0000-0003-2823-4530
https://orcid.org/0000-0001-9483-4206
identifier_str_mv 1662-453X
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Frontiers in Neuroscience
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.publisher.initials.fl_str_mv UFMG
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv ICB - DEPARTAMENTO DE FISIOLOGIA E BIOFÍSICA
ICB - DEPARTAMENTO DE MORFOLOGIA
ICB - DEPARTAMENTO DE PARASITOLOGIA
publisher.none.fl_str_mv Universidade Federal de Minas Gerais
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFMG
instname:Universidade Federal de Minas Gerais (UFMG)
instacron:UFMG
instname_str Universidade Federal de Minas Gerais (UFMG)
instacron_str UFMG
institution UFMG
reponame_str Repositório Institucional da UFMG
collection Repositório Institucional da UFMG
bitstream.url.fl_str_mv https://repositorio.ufmg.br/bitstream/1843/56302/1/License.txt
https://repositorio.ufmg.br/bitstream/1843/56302/2/Angiotensin-%281-7%29%20central%20mechanisms%20after%20ICV%20infusion%20in%20hypertensive%20transgenic%20%28mRen2%2927%20rats.pdf
bitstream.checksum.fl_str_mv fa505098d172de0bc8864fc1287ffe22
74f9266c9a8ba2aaa978267f85ab148e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)
repository.mail.fl_str_mv
_version_ 1801676679655981056